Advertisement
| azelastine ophthalmic 0.05 ophthalmic solution: Handbook of Emergency Ophthalmology Brit Long, Alex Koyfman, 2018-06-21 This book provides emergency physicians with an easy-to-use guide for diagnosing and treating ophthalmologic conditions in the emergency department. Ophthalmologic complaints are very common, but many emergency physicians are not as confident as they would like to be when evaluating and managing these conditions. This book answers that need by giving step-by-step instructions on how to diagnose and treat common eye conditions, including glaucoma, infections, neuro-ophthalmologic conditions, and trauma. For each disorder, the book discusses presentation/symptoms, physical examination techniques, lab and imaging findings, differential diagnoses, treatment guidelines, and referral suggestions. The text is filled with images that clearly present these common ophthalmologic complaints and conditions and guide the emergency physician to an accurate and swift diagnosis. Handbook of Emergency Ophthalmology is an essential resource for emergency physicians, residents, medical students, nurses, and other healthcare workers who evaluate and manage patients with ophthalmologic conditions. |
| azelastine ophthalmic 0.05 ophthalmic solution: Ocular Toxicology Keith Green, O. Hockwin, Ramesh C. Tripathi, I. Weisse, 2012-12-06 On behalf of the editorial board and the organizing committee of the 4th congress of the International Society of Ocular Toxicology (I SOT), held in AnnecyNeyrier du Lac, France, October 9 -13, 1994, we are pleased to present to the ocular toxicology community this indexed volume of our congress proceedings. The 4th congress was designed primarily to facilitate and update the knowledge in ocular electrophysiology and ocular pharmacokinetics, in both the clinical and preclinical aspects. The outcome of this 4th congress, established in this volume, is a useful contribution to the meth odology in both fields and will hopefully assist in the evaluation and interpretation of ocular findings recorded in animal studies on drugs and other chemicals, in order to protect human health. Undoubtedly, work on the mechanisms of ocular toxicology in the process of pharmaceutical development must continue and these proceedings, embodying the presented papers, will add to the data base. The editors, the congress organizing committee and the members of the International Society of Ocular Toxicology thank the speakers who gave their time, knowledge, and expertise to assist us in this project. The following manuscripts contain the main substance of each of the platform presentations and, in some cases, much more. Moreover, our thanks go to all the participants coming from a range of background- regulatory, academic and industrial -for their attention and excellent contributions during the discussion. |
| azelastine ophthalmic 0.05 ophthalmic solution: Allergic Diseases of the Eye Mark B. Abelson, 2000 This reference provides comprehensive coverage of the basic mechanisms and pathophysiology of ocular allergies and details a broad range of the latest therapeutic agents and their appropriate clinical applications. |
| azelastine ophthalmic 0.05 ophthalmic solution: Advanced Concepts in Human Immunology: Prospects for Disease Control Pooja Jain, Lishomwa C. Ndhlovu, 2020-08-11 This book highlights information derived primarily from clinical samples, with particular reference to theoretical and scientific aspects of the human immune system. This text will focus on topics that range from host-pathogen interactions in infectious disease to host immune response in cancer, allergic diseases, neuroinflammatory diseases, and autoimmune disorders. The reader will also have a well-rounded understanding of the behavior of the immune system with particular emphasis on the role of immunoproteomics in immunotherapy, neuroprotective immunity for neurodegenerative and neuroinfectious disease, leukemia-associated dendritic cell induction of adaptive immunity dysregulation, and the role of immune checkpoint inhibitors in cancer, infection, as well as neuroinflammation. Taken together, the contents of this book are intended for both clinicians and researchers in academia and industry. |
| azelastine ophthalmic 0.05 ophthalmic solution: Koda-Kimble and Young's Applied Therapeutics Brian K. Alldredge, Robin L. Corelli, Michael E. Ernst, 2012-02-01 Rev. ed. of: Applied therapeutics: the clinical use of drugs / edited by Mary Anne Koda-Kimble ... [et al.]. 9th ed. c2009. |
| azelastine ophthalmic 0.05 ophthalmic solution: Ocular Allergy Leonard Bielory, 2008 Topics include: Introduction- Immunopathophysiology and Classification of Ocular Allergy, OcularMast CDermatologicdisorders of the Eyelidsells and Mediators,SeasonalAllergic Conjunctivitis&Perennial Allergic Conjunctivitis,VernalKeratoconjunctivitis,GiantPapillary Conjunctivitis,Dermatologicdisorders of the Eyelids,ContactDermatitis of the Eyelids,AutoimmuneDisorders of the Anterior Surface,PediatricConcerns of Ocular Inflammation,ContactLens,OcularAllergy Treatment,Adverse(Allergic) Effects of GlaucomaMedications |
| azelastine ophthalmic 0.05 ophthalmic solution: Ocular Surface Disorders Jose M Benitez-del-Castillo, Michael A Lemp, 2013-11-04 Current knowledge of the epidemiology, clinical expression, pathophysiology and available medical and surgical therapy for ocular surface diseases, providing an invaluable text for ocular surface specialists, general ophthalmologists, optometrists and residents. |
| azelastine ophthalmic 0.05 ophthalmic solution: Pediatric Allergy: Principles and Practice E-Book Donald Y. M. Leung, Hugh Sampson, Raif Geha, Stanley J. Szefler, 2010-10-13 Pediatric Allergy supplies the comprehensive guidance you need to diagnose, manage, and treat virtually any type of allergy seen in children. Drs. Leung, Sampson, Geha, and Szefler present the new full-color second edition, with coverage of the diagnosis and management of anaphylaxis, the immune mechanisms underlying allergic disease, the latest diagnostic tests, and more. Treat the full range of pediatric allergic and immunologic diseases through clinically focused coverage relevant to both allergists and pediatricians. Understand the care and treatment of pediatric patients thanks to clinical pearls discussing the best approaches. Easily refer to appendices that list common food allergies and autoantibodies in autoimmune diseases. Apply the newest diagnostic tests available—for asthma, upper respiratory allergy, and more—and know their benefits and contraindications. Treat the allergy at its source rather than the resulting reactions through an understanding of the immune mechanisms underlying allergic diseases. Get coverage of new research that affects methods of patient treatment and discusses potential reasons for increased allergies in some individuals. Better manage potential anaphylaxis cases through analysis of contributing facts and progression of allergic disease. Effectively control asthma and monitor its progression using the new step-by-step approach. Eliminate difficulty in prescribing antibiotics thanks to coverage of drug allergies and cross-reactivity. |
| azelastine ophthalmic 0.05 ophthalmic solution: Ocular Surface Disease: Cornea, Conjunctiva and Tear Film Edward J Holland, Mark J Mannis, W. Barry Lee, 2013-05-17 Ocular Surface Disease: Cornea, Conjunctiva and Tear Film incorporates current research and the latest management strategies as well as classification systems and treatment paradigms for all forms of ocular surface disease. This is the first comprehensive resource that helps you to meet ocular surface disease challenges effectively using today's best medical and surgical approaches. Get the complete, evidence-based guidance you need to provide optimal care for your patients with ocular surface disease. Implement the latest drug treatments and surgical interventions to provide better outcomes with fewer complications. Hone and expand your surgical skills by watching videos of leading experts performing advanced procedures including ocular surface transplantation techniques; amniotic membrane transplantation; pterygium surgery; lamellar keratoplasty (DALK) in ocular surface disease; and keratoprosthesis surgery. Visualize how to proceed by reviewing detailed, full-color images and consulting new classification systems and treatment paradigms for mild to severe forms of ocular surface disease. Take it with you anywhere! Access the full text, downloadable image library, video clips, and more online at expertconsult.com. |
| azelastine ophthalmic 0.05 ophthalmic solution: Ocular Therapeutics Ashok Garg, 2013-03-31 The third edition of Ocular Therapeutics brings practitioners up to date with the latest advances in ophthalmic drugs. Divided into three sections, the book begins with discussion on the physiology of the eye, drug administration and the fundamental role of ocular therapeutics. The second section examines the application of ocular therapeutics in ophthalmic surgery for many different disorders and the final section discusses recent advances and future developments. This new edition has been fully updated with the addition of new drugs and delivery systems, covering all groups of drugs used worldwide in different clinical conditions of the eye. Written by recognised international experts, many from the USA, the book is presented in an easy to read format and includes nearly 430 well-illustrated colour figures, tables, flow diagrams and chemical formulas. Key points New edition bringing ophthalmologists up to date with latest advances in ophthalmic drugs Includes new drugs and delivery systems for all groups of drugs used worldwide Written by recognised international experts Nearly 430 figures, tables, flow diagrams and chemical formulas Previous edition published in 2006 |
| azelastine ophthalmic 0.05 ophthalmic solution: Ocular Surface Disease: Cornea, Conjunctiva and Tear Film E-Book Edward J Holland, Mark J Mannis, W. Barry Lee, 2013-06-24 Ocular Surface Disease: Cornea, Conjunctiva and Tear Film incorporates current research and the latest management strategies as well as classification systems and treatment paradigms for all forms of ocular surface disease. This is the first comprehensive resource that helps you to meet ocular surface disease challenges effectively using today's best medical and surgical approaches. - Get the complete, evidence-based guidance you need to provide optimal care for your patients with ocular surface disease. - Implement the latest drug treatments and surgical interventions to provide better outcomes with fewer complications. - Hone and expand your surgical skills by watching videos of leading experts performing advanced procedures including ocular surface transplantation techniques; amniotic membrane transplantation; pterygium surgery; lamellar keratoplasty (DALK) in ocular surface disease; and keratoprosthesis surgery. - Visualize how to proceed by reviewing detailed, full-color images and consulting new classification systems and treatment paradigms for mild to severe forms of ocular surface disease. - Take it with you anywhere! Access the full text, downloadable image library, video clips, and more online at expertconsult.com. |
| azelastine ophthalmic 0.05 ophthalmic solution: Pharmacology of Ocular Therapeutics Thirumurthy Velpandian, 2016-02-29 This book comprises an integrated review of ocular therapeutics across all relevant fields. It addresses the real-world requirements of ophthalmologists, pharmacists and optometrists, as observed through working alongside these practitioners for two decades. Knowledge surrounding agents used in ophthalmic practice has, historically, been scattered. The book facilitates understanding of ocular drug therapy by compiling all key aspects of the pharmacology, toxicology, pharmaceutical science, ocular biochemistry and cell biology of these agents. Chapters detail drug transfer across barriers, systemic toxicity of topically applied drugs, autonomic drugs used for diagnostics, as well as anti-inflammatory, antiallergic, glaucoma and antimicrobial therapies, and avenues for the development of new ocular drugs. Applications of extemporaneously prepared formulations are described to inform day-to-day clinical practice. The use of mucoadhesive polymers in tear substitutes, ocular drug delivery systems, stem cell therapy, pharmacogenomics and antiangiogenic ocular chemotherapy are also explored. The book also provides insights from drugs of herbal origin, and a historical perspective on drugs for ocular use. Practicing and resident ophthalmologists, optometrists, pharmacists, nursing professionals, scholars in ocular drug research and students will equally benefit from this comprehensive guide. |
| azelastine ophthalmic 0.05 ophthalmic solution: Pharmacopoeia Steven M. Green, 2009 The Most Popular and Most Trusted Portable Drug Dosing Reference Available!Updated fully for 2009, the 23rd Edition of the Tarascon Pocket Pharmacopoeia continues the high-quality tradition of a convenient, organized, and concise pocket manual packed with vital drug information meticulously peer-reviewed by experts and clinicians of multiple specialties. It details typical drug dosing (both FDA approved and off-label uses), available trade and generic formulations, metabolism, safety in pregnancy, and lactation, relative drug pricing information, Canadian trade names, and an herbal & alternative therapies section. Multiple tables supplement the drug content, including opioid equivalency, emergency drug infusions, cardiac dysrhythmis protocols, pediatric drug dosing, and much more! |
| azelastine ophthalmic 0.05 ophthalmic solution: Plumb's Veterinary Drug Handbook Donald C. Plumb, 2018-02-21 Plumb’s Veterinary Drug Handbook, Ninth Edition updates the most complete, detailed, and trusted source of drug information relevant to veterinary medicine. Provides a fully updated edition of the classic veterinary drug handbook, with carefully curated dosages per indication for clear guidance on selecting a dose Features 16 new drugs Offers an authoritative, complete reference for detailed information about animal medication Designed to be used every day in the fast-paced veterinary setting Includes dosages for a wide range of species, including dogs, cats, exotic animals, and farm animals |
| azelastine ophthalmic 0.05 ophthalmic solution: Applied Therapeutics Caroline S. Zeind, Michael G. Carvalho, Judy W. Cheng, Kathy Zaiken, Trisha LaPointe, 2023-01-06 50th Anniversary Edition of the groundbreaking case-based pharmacotherapy text, now a convenient two-volume set. Celebrating 50 years of excellence, Applied Therapeutics, 12th Edition, features contributions from more than 200 experienced clinicians. This acclaimed case-based approach promotes mastery and application of the fundamentals of drug therapeutics, guiding users from General Principles to specific disease coverage with accompanying problem-solving techniques that help users devise effective evidence-based drug treatment plans. Now in full color, the 12th Edition has been thoroughly updated throughout to reflect the ever-changing spectrum of drug knowledge and therapeutic approaches. New chapters ensure contemporary relevance and up-to-date IPE case studies train users to think like clinicians and confidently prepare for practice. |
| azelastine ophthalmic 0.05 ophthalmic solution: Medical Pharmacology and Therapeutics E-Book Derek G. Waller, Tony Sampson, 2013-08-07 This book covers all the pharmacology you need, from basic science pharmacology and pathophysiology, through to clinical pharmacology to therapeutics, in line with the integrated approach of new medical curricula. The first section covers the basic principles, and the rest is organised by body systems. The book ends with sections on toxicity and prescribing practice. Integrates basic science pharmacology, clinical pharmacology and therapeutics Brief review of pathophysiology of major diseases Case histories and multiple choice questions (and answers) Tabular presentation of all common drugs within each class Section on further reading Kinetics chapter simplified with more practical examples Includes more on genetic issues Drug tables made more concise to make information more accessible Fully updated to reflect current clinical practice |
| azelastine ophthalmic 0.05 ophthalmic solution: Itch E. Carstens, Tasuku Akiyama, 2014-02-25 Advances in itch research have elucidated differences between itch and pain but have also blurred the distinction between them. There is a long debate about how somatic sensations including touch, pain, itch, and temperature sensitivity are encoded by the nervous system. Research suggests that each sensory modality is processed along a fixed, direct-line communication system from the skin to the brain. Itch: Mechanisms and Treatment presents a timely update on all aspects of itch research and the clinical treatment of itch that accompanies many dermatological conditions including psoriasis, neuropathic itch, cutaneous t-cells lymphomas, and systemic diseases such as kidney and liver disease and cancer. Composed of contributions from distinguished researchers around the world, the book explores topics such as: Neuropathic itch Peripheral neuronal mechanism of itch The role of PAR-2 in neuroimmune communication and itch Mrgprs as itch receptors The role of interleukin-31 and oncostatin M in itch and neuroimmune communication Spinal coding of itch and pain Spinal microcircuits and the regulation of itch Examining new findings on cellular and molecular mechanisms, the book is a compendium of the most current research on itch, its prevalence in society, and the problems associated with treatment. |
| azelastine ophthalmic 0.05 ophthalmic solution: Handbook of Pharmaceutical Manufacturing Formulations, Third Edition Sarfaraz K. Niazi, 2019-12-09 The Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume Six, Sterile Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this sixth volume of a six-volume set, compiles data from FDA and EMA new drug applications, patents and patent applications, and other sources of generic and proprietary formulations including author’s own experience, to cover the broad spectrum of cGMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent. Features: Largest source of authoritative and practical formulations, cGMP compliance guidance and self-audit suggestions Differs from other publications on formulation science in that it focuses on readily scalable commercial formulations that can be adopted for cGMP manufacturing Tackles common difficulties in formulating drugs and presents details on stability testing, bioequivalence testing, and full compliance with drug product safety elements Written by a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines |
| azelastine ophthalmic 0.05 ophthalmic solution: PDR for Ophthalmic Medicines , 2007 This essential reference guide for eye-care professionals contains information on the drugs and equipment used in the fast-changing ophthalmology and optometry fields. The detailed encyclopedia is enhanced by color product photographs and information on all types of contact lenses and specialized instruments. |
| azelastine ophthalmic 0.05 ophthalmic solution: Principles and Practice of Ophthalmology E-Book Daniel M. Albert, Joan W. Miller, Dimitri T. Azar, Barbara A. Blodi, 2008-02-27 Inside the 3rd edition of this esteemed masterwork, hundreds of the most distinguished authorities from around the world provide today's best answers to every question that arises in your practice. They deliver in-depth guidance on new diagnostic approaches, operative technique, and treatment option, as well as cogent explanations of every new scientific concept and its clinical importance. With its new streamlined, more user-friendly, full-color format, this 3rd edition makes reference much faster, easier, and more versatile. More than ever, it's the source you need to efficiently and confidently overcome any clinical challenge you may face. Comprehensive, authoritative, and richly illustrated coverage of every scientific and clinical principle in ophthalmology ensures that you will always be able to find the guidance you need to diagnose and manage your patients' ocular problems and meet today's standards of care. Updates include completely new sections on Refractive Surgery and Ethics and Professionalism... an updated and expanded Geneitcs section... an updated Retina section featuring OCT imaging and new drug therapies for macular degeneration... and many other important new developments that affect your patient care. A streamlined format and a new, more user-friendly full-color design - with many at-a-glance summary tables, algorithms, boxes, diagrams, and thousands of phenomenal color illustrations - allows you to locate the assistance you need more rapidly than ever. |
| azelastine ophthalmic 0.05 ophthalmic solution: Drugs for Pregnant and Lactating Women E-Book Carl P. Weiner, 2018-10-17 Logically organized and easy to use, Drugs for Pregnant and Lactating Women, 3rd Edition, is your #1 resource for details on how virtually all of today's drugs and herbal supplements interact with pregnancy and lactation. More than just a dosing manual, this unique title by Dr. Carl P. Weiner fully explains whether each drug is FDA-approved for use by expecting or nursing mothers, is known to be safe for use, or is known to pose a danger. With up-to-date coverage of nearly 2,000 substances, it provides the thorough details you need to choose the most effective course of treatment. - Uses a consistent, easy-to-follow format for each substance: generic and trade name • class • indications • mechanism of action • dosage, with contraindications and cautions • maternal considerations • fetal considerations • drug interactions • breastfeeding safety • references • and summary information. - Describes over-the-counter drugs and alternative medications as well as prescription drugs. - Uses an eye-catching icon to highlight known teratogens. - Includes international drug names to give this reference a global perspective. - Features new letter thumb tabs for easier navigation. - Includes dozens of new drugs and thorough updates throughout. - Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, images, videos (including video updates), glossary, and references from the book on a variety of devices. |
| azelastine ophthalmic 0.05 ophthalmic solution: Frequently Prescribed Medications Michael Mancano, Jason Gallagher, 2010-11-12 Health Sciences & Professions |
| azelastine ophthalmic 0.05 ophthalmic solution: Mayo Clinic Internal Medicine Concise Textbook Thomas M. Habermann, Amit K. Ghosh, 2007-11-01 Now for the first time, a new diagnosis and treatment guide with even more focus on the most commonly encountered disorders than ever before. All major internal medicine diseases and disorders are covered in this new succinct evidence-based guide to treatment and diagnosis in internal medicine. Organized by body system, and focused on critical cor |
| azelastine ophthalmic 0.05 ophthalmic solution: Ocular Therapeutics Thomas Yorio, Abbott Clark, Martin B Wax, 2011-04-28 Ocular Therapeutics: Eye on New Discovery focuses on emerging areas in ocular research, from new approaches to dry eye to gene therapy in the management of retinal diseases. This comprehensive book features more than 25 chapters of information that will be vital for ocular investigators and ophthalmologists bringing them new information on promising therapeutics. It is the intent of this book to provide not only information on current approaches to treatment, but also in giving the reader a greater understanding as to what may become available for treating a number of important eye diseases. Each chapter features some new aspect of treatment that holds great promise for the future. The approach has been to concentrate on those areas of ocular diseases that are more prevalent. It also features new insight for drug delivery and for managing devasting diseases, such as macula edema and glaucoma, two of the leading causes of blindness in the United States. This book will serve as an important resource as it contains a number of relevant references highlighted for their importance to the field. New investigators will be able to obtain an historical perspective for each of the topics and to develop an understanding of the new research directions that are underway. Ocular Therapeutics: Eye on New Discovery is more than a reference book, as it also provides an important glimpse into the near future.* Contains information that is vital for ocular investigators and ophthalmologists bringing them new information on promising therapeutics.* Provides not only information on current approaches to treatment, but also gives the reader a greater understanding as to what may become available for treating a number of important eye diseases.* Historical perspective for each of the topics as well as an important glimpse into the near future to develop an understanding of the new research directions underway.* New insight for drug delivery and for managing devastating diseases, such as macula edema and glaucoma, two of the leading causes of blindness in the United States |
| azelastine ophthalmic 0.05 ophthalmic solution: Mayo Clinic Internal Medicine Board Review Amit Ghosh, MD, 2010-09-23 Written by experienced faculty at Mayo Clinic, The NINTH EDITION is a completely revised and updated study guide that has proved invaluable for the American Board of Internal Medicine certification or maintenance of certification examination as well as for general practice review by physicians around the world. |
| azelastine ophthalmic 0.05 ophthalmic solution: Frontiers in Clinical Drug Research - Anti-Allergy Agents Atta-ur-Rahman, 2018-07-11 Frontiers in Clinical Drug Research - Anti-Allergy Agents is a book series comprising of a selection of updated review articles relevant to the recent development of pharmacological agents used for the treatment of allergies. The scope of the reviews includes clinical trials of anti-inflammatory and anti-allergic drugs, drug delivery strategies used to treat specific allergies (such as inflammation, asthma and dermatological allergies), lifestyle dependent modes of therapies and the immunological or metabolic mechanisms that are of interest to researchers as targets for new drugs. The third volume of this series brings 5 reviews which cover the following topics: H1 receptor selectivity, chronic spontaneous urticaria therapy, smooth muscle cell Ca2+ signaling pathway targeting for asthma therapy, allergic rhinitis and endosomal toll-like receptors. Frontiers in Clinical Drug Research - Anti-Allergy Agents will be of interest to immunologists and drug discovery researchers interested in anti-allergic drug therapy as the series provides relevant cutting edge reviews written by experts in this rapidly expanding field. |
| azelastine ophthalmic 0.05 ophthalmic solution: Evidence-Based Ophthalmology Richard Wormald, Katherine Henshaw, Liam Smeeth, 2008-04-30 Evidence-Based Ophthalmology offers a unique approach to managing eye disease. From systematic reviewing of evidence, this book provides an overview of techniques for optimum management in key areas, including glaucoma, cataract and retinal disease – an invaluable reference source for practitioners worldwide representing an important contribution to the literature. Key Features International authorship by leading Cochrane participants An unbiased method for summarising and disseminating the evidence Identifies gaps in evidence, and therefore research opportunities Free-access update website giving the latest trial data and recommendations for implementation in practice Includes a free fully searchable CD-ROM |
| azelastine ophthalmic 0.05 ophthalmic solution: Clinical Contact Lens Practice Edward S. Bennett, Barry A. Weissman, 2005 This comprehensive text and reference addresses the full scope of contemporary contact lens science and practice. With two expert editors and 100 first-rate contributors, the book presents practitioners and students in optometry and ophthalmology with key facts on corneal anatomy, recent research, contact lens design, patient evaluation, clinical applications, patient education, and complications of contact lens wear. More than 600 illustrations complement the text. Clinical Contact Lens Practice will be the standard text for required contact lens courses and will be an invaluable everyday reference for practitioners. |
| azelastine ophthalmic 0.05 ophthalmic solution: Practice Guidelines for Family Nurse Practitioners - E-Book Karen Fenstermacher, Barbara Hudson, 2022-12-12 **American Journal of Nursing (AJN) Book of the Year Awards, 1st Place in Advanced Practice Nursing, 2023** **American Journal of Nursing (AJN) Book of the Year Awards, 3rd Place in Adult Primary Care, 2023** The latest evidence-based guidelines keep you up to date for FNP practice! With updated content and full-color illustrations, Practice Guidelines for Family Nurse Practitioners, 6th Edition provides essential information on the most current national and international guidelines and evidence-based protocols for primary care patients of all ages. Key details are easy to find with the book's full-color format, concise outline-style guidelines, and abundant summary tables and charts. In addition to coverage of the most common conditions seen in outpatient settings, this edition includes the latest information on topics such as COVID-19 and STDs. Plus, the popular Practice Pearls boxes have been expanded throughout the book. - Current, evidence-based guidelines for patients of all ages provide the latest guidance for managing disorders commonly seen by FNPs in primary care settings. - Concise outline format makes it easy to quickly locate essential information. - Quick-reference tables and charts include pediatric conditions charts, comparative charts for similar disorders, and health maintenance guidelines charts. - Need-to-know coverage of the most common disorders helps familiarize practitioners with situations frequently encountered in clinical practice. - Content highlights include not-to-be-missed content, non-urgent/non-emergent interprofessional referrals, and urgent/emergent interprofessional referrals. - Practice Pearls highlight practical clinical wisdom gleaned from the authors' extensive practice knowledge base. - NEW! Updated content reflects the most common conditions and the latest national and international guidelines and evidence-based protocols, including guidelines for COVID-19 and new CDC guidelines for STDs. - NEW! Full-color illustrations and design with high-visibility Not-to-be-Missed points and referral information aid learning and comprehension. - NEW! Expanded Practice Pearls emphasize the variety in appearance of certain findings depending on skin tone. - NEW! Combined cardiac and vascular chapters make information more intuitive and easier to reference. - NEW! Expanded dermatology content reflects conditions commonly seen in family practice. - NEW! Topics and conditions presented in alphabetical order within each chapter improve reference value, and a new alphabetical list of conditions is located on the inside the front cover of the print edition. - NEW! Focused physical examinations are integrated into each body systems chapter as appropriate. - NEW! Two additional appendices provide quick access to an acetaminophen dosing chart and an ibuprofen dosing chart. |
| azelastine ophthalmic 0.05 ophthalmic solution: Pharmacology of Itch Alan Cowan, Gil Yosipovitch, 2015-04-10 Basic research on the pharmacology of itch has exploded in the wake of two very influential papers that were published in Nature (2007) and Science (2009). Long overlooked as a milder form of pain, itching has rapidly gained a new appreciation in both research and clinical communities because of its complexity and its negative effects on the quality of life of the distressed patients. Like pain, not all itches are the same. Unlike pain, there are no standard drugs equivalent to aspirin and morphine. Epidemiological studies emphasize the high incidence and economic costs of itch (pruritus). It is the most prevalent symptom of a wide variety of allergic and inflammatory skin conditions (e.g., psoriasis, atopic dermatitis), is associated with several systemic diseases (e.g., chronic kidney and liver disease), and occurs in patients undergoing hemodialysis, spinal administration of opioids, and in those suffering from AIDS. The reader will learn about the multiple pathways for itch and their interactions with pain. The relationship between these closely related, yet distinct sensory phenomena, will be emphasized. Both itch and pain use several common molecules to send signals to the brain. Thus, drugs that have been, and are being, developed as analgesics may also attenuate intractable itch. This has been an exciting and very necessary turn of events since traditional H-1 receptor antagonists are ineffective in blocking the pruritus associated with kidney failure and cholestasis. The clinical chapters will provide insights into contemporary treatment regimens for pruritus in different human scenarios. |
| azelastine ophthalmic 0.05 ophthalmic solution: Cornea E-Book Jay H. Krachmer, Mark J Mannis, Edward J Holland, 2010-10-27 Cornea, edited by Drs. Krachmer, Mannis & Holland, is the only truly comprehensive clinical reference available that covers external disease, anterior uveitis, and the expanding range of contemporary corneal surgery. In this Third Edition, state-of-the-art coverage, 25 brand-new chapters, and 45 new videos provide expert guidance on performing femtosecond-assisted penetrating keratoplasty, DSAEK, deep anterior lamellar keratoplasty, and many other cutting-edge techniques. Plus, you’ll have easy access to the complete contents and illustrations online at expertconsult. Overcome any clinical challenge related to the cornea, external disease, anterior uveitis, and the expanding range of contemporary corneal surgery with the most complete, authoritative guidance source available. Get superb visual guidance with exceptionally clear illustrations, diagnostic images, and step-by-step surgical photographs. Access the complete contents and illustrations online at expertconsult. Make optimal use of Anterior Segment OCT to plan and choose treatment options and assess post-operative recovery. Master the latest surgical techniques—including femtosecond-assisted penetrating keratoplasty, DSAEK, and deep anterior lamellar keratoplasty—thanks to 25 brand-new chapters and 45 new videos on DVD (a total of 3 hours running time). Understand the full spectrum of corneal diseases with coverage of the new corneal dystrophy classification that incoporates current genetic, clinical, and pathologic information. |
| azelastine ophthalmic 0.05 ophthalmic solution: Mayo Clinic Medical Manual and Mayo Clinic Internal Medicine Review H.M. Oliveira Guilherme, Gillian C. Nesbitt, Joseph G. Murphy, Thomas M. Habermann, 2007-06-14 Written by seasoned faculty at the Mayo Clinic, this Seventh Edition is a completely revised and updated study tool that has proven invaluable for the American Board of Internal Medicine certification or recertification. Using this source, readers will access a virtual blueprint for exam preparation and acquire clear guidance on question format, types of questions, and hints on topics commonly encountered on the test. |
| azelastine ophthalmic 0.05 ophthalmic solution: Toxicological Aspects of Drug-Facilitated Crimes Pascal Kintz, 2014-03-22 Toxicological Aspects of Drug-Facilitated Crimes provides readers with an overview of the field of DFC: its history, toxicological effects, analysis, interpretation of results, the roles that age, gender and race may play, and clinical presentations of these drugs. The most commonly used drugs in DFC are addressed (alcohol, cannabis, MDMA, and cocaine), as well as an emerging range of pharmaceuticals (benzodiazepines, hypnotics, sedatives, neuroleptics, histamine H1-antagonists, or anesthetics), which are becoming more widely used, but are more difficult to detect. Edited by a world-renowned expert in the field of Forensic and Analytical Toxicology, Pascal Kintz, this book investigates toxicants of emerging concern and brings together a number of experts in the field to address the most recent discoveries on DFC toxicology. - Brings together the latest research on the toxicological analysis of drug-facilitated crimes (DFC), with real-life case studies - Provides up-to-date analytical techniques for determining toxicity levels in blood, urine, and hair - Covers all types of toxicants involved in DFC, including alcohol, cannabis, MDMA, and a wide variety of pharmaceuticals |
| azelastine ophthalmic 0.05 ophthalmic solution: Allergy and Allergic Diseases A. Barry Kay, Jean Bousquet, Patrick G. Holt, Allen P. Kaplan, 2009-01-26 Reserve your copy now This two volume book is an outstanding reference source on allaspects of allergy and allergic diseases. Covering virtually everyallergic condition, from the immunological and molecular basis ofthe allergic response to future trends in allergic diseaseprevention, this new international editorial team (A.B.Kay, JeanBousquet, Pat Holt and Allen Kaplan) have completely revised andupdated the text, from both a scientific and clinical perspective.References will continue to be added to the text until it goes topress making this the most up-to-date book available in thefield. This second edition consists of more than 1,800 pages containedwithin 98 chapters. The price includes a fully searchable companion CD ROM with thecomplete text and over 300 images from the book in full colour. |
| azelastine ophthalmic 0.05 ophthalmic solution: Usp39-Nf34 United States Pharmacopeial Convention, 2015-11-01 |
| azelastine ophthalmic 0.05 ophthalmic solution: Tarascon Pocket Pharmacopoeia 2009: Classic Shirt-Pocket Edition Richard J. Hamilton, 2008-10-23 The most popular and most trusted portable drug dosing Reference available!Recently updated for 2008, the Tarascon Pocket Pharamopoeia continues the high-quality tradition of a convenient, organized, and concise pocket manual packed with vital drug information meticulously peer-viewed by experts and clinicians of multiple specialties. It details typical drug dosing (both FDA approved and off-label uses), available trade and generic formulations, metabolism, safety in pregnancy and lactation, relative drug pricing information, Canadian trade names, and an Herbal & Alternative Therapies section. Multiple invaluable tables supplement the drug content, including opiod equivalency, emergency drug infusion, cariac dysrthythimia protocols pediatric drug dosing and much more! |
| azelastine ophthalmic 0.05 ophthalmic solution: Allergens and Allergen Immunotherapy Richard F. Lockey, Dennis K. Ledford, 2020-02-26 The sixth edition of Lockey and Ledford's Allergens and Allergen Immunotherapy continues to provide comprehensive coverage of all types of allergens and allergen vaccines, providing clinicians the essential information they need to accurately diagnose and manage all allergic conditions. With new and updated chapters, the sixth edition is the most up-to-date, single resource on allergy and immunotherapy. Key Features Completely revised and updated Detailed single source reference on allergy and immunotherapy Reorganized to provide clinicians with essential information to make diagnoses and offer the best treatments |
| azelastine ophthalmic 0.05 ophthalmic solution: Ferri's Clinical Advisor 2022 Fred F. Ferri, 2021-06-09 Access immediate answers on the medical conditions you’re likely to see with this unique, bestselling resource! Ferri’s Clinical Advisor 2022 uses the popular 5 books in 1 format to deliver vast amounts of information in a clinically relevant, user-friendly manner. This practical reference is updated annually to provide easy access to answers on over 1,000 common medical conditions, including diseases and disorders, differential diagnoses, clinical algorithms, laboratory tests, and clinical practice guidelines—all carefully reviewed by experts in key clinical fields. Extensive algorithms, along with hundreds of clear photographs, illustrations, diagrams, and tables, ensure that you stay current with today's medical practice. Contains significant updates throughout, covering all aspects of current diagnosis and treatment. Features 30 all-new topics including Covid-19 disease, anal cancer, electronic cigarette or vaping–associated lung injury (EVALI), gaming disorder, early pregnancy loss, smoke inhalation injury, and subjective cognitive decline, among others. Includes useful appendices covering common herbs in integrated medicine and herbal activities against pain and chronic diseases; care of the transgender patient, palliative care; preoperative evaluation, and more. Offers online access to Patient Teaching Guides in both English and Spanish. |
| azelastine ophthalmic 0.05 ophthalmic solution: Index Medicus , 2002 Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings. |
| azelastine ophthalmic 0.05 ophthalmic solution: Tarascon Pharmacopoeia 2012 Deluxe Lab Coat Edition Editor in Chief, Richard J. Hamilton MD FAAEM FACMT FACEP, Tarascon, 2011-11-23 Used by prescribers around the world, including: physicians, pharmacists, nurses, physician assistants, dentists and medical transcriptionist, the Tarascon Pharmacopoeia,® 2012 Deluxe Lab Coat Edition continues its tradition as the leading portable drug reference packed with vital drug information to help clinicians make better decisions at the point of care. The Tarascon Pharmacopoeia,® 2012 Deluxe Lab Coat Edition is an expanded version of the Classic Shirt-Pocket Edition, containing more drugs, evidence-based off-label indications for adults and pediatric patients, and additional tables. The 2012 Deluxe Lab Coat Edition also includes typical drug dosing (all FDA approved), available trade and generic formulations, metabolism, safety in pregnancy and lactation, relative drug pricing information, Canadian trade names, and an herbal & alternative therapies section. Multiple tables supplement the drug content, including opioid equivalency, emergency drug infusions, cardiac dysrhythmia protocols, pediatric drug dosing, and much more. Each edition is meticulously peer-reviewed by experts and are also available in for iPhone, iPad, Android and Blackberry devices. |
Azelastine nasal Uses, Side Effects & Warnings - Drugs.com
Aug 3, 2023 · Azelastine nasal (for the nose) is an antihistamine that is used to treat sneezing, runny or stuffy nose, itching, and other nasal symptoms …
Azelastine (nasal route) - Mayo Clinic
Apr 1, 2025 · Azelastine nasal spray is used to help relieve symptoms (eg, stuffy or runny nose, itching, sneezing) of seasonal (short-term) or …
Azelastine - Wikipedia
Azelastine, sold under the brand name Astelin among others, is a H 1 receptor-blocking medication primarily used as a nasal spray to treat allergic rhinitis …
Azelastine nasal (Astelin, Astepro Allergy, Children’s
Dec 27, 2024 · Overview: Nasal azelastine is an antihistamine nasal spray used to treat symptoms, including stuffy nose, runny nose, …
Azelastine: Side Effects, Dosage, Uses, and More - He…
Oct 18, 2018 · Azelastine nasal spray is a prescription medication that's used to treat seasonal or year-round allergic rhinitis (nasal allergies). It can treat …
Azelastine nasal Uses, Side Effects & Warnings - Drugs.com
Aug 3, 2023 · Azelastine nasal (for the nose) is an antihistamine that is used to treat sneezing, runny or stuffy nose, itching, and other nasal symptoms of allergies. Azelastine nasal is for use …
Azelastine (nasal route) - Mayo Clinic
Apr 1, 2025 · Azelastine nasal spray is used to help relieve symptoms (eg, stuffy or runny nose, itching, sneezing) of seasonal (short-term) or perennial (year-round) allergic rhinitis (hay …
Azelastine - Wikipedia
Azelastine, sold under the brand name Astelin among others, is a H 1 receptor-blocking medication primarily used as a nasal spray to treat allergic rhinitis (hay fever) and as eye …
Azelastine nasal (Astelin, Astepro Allergy, Children’s ... - WebMD
Dec 27, 2024 · Overview: Nasal azelastine is an antihistamine nasal spray used to treat symptoms, including stuffy nose, runny nose, and sneezing, from allergic rhinitis and …
Azelastine: Side Effects, Dosage, Uses, and More - Healthline
Oct 18, 2018 · Azelastine nasal spray is a prescription medication that's used to treat seasonal or year-round allergic rhinitis (nasal allergies). It can treat symptoms such as sneezing and runny …
azelastine - GoodRx
Jun 23, 2024 · Azelastine nasal spray is an antihistamine that treats allergies and nasal symptoms, such as runny or stuffy nose. The 0.1% and 0.15% strengths of the azelastine …
Azelastine Nasal Spray: MedlinePlus Drug Information
Prescription and nonprescription (over the counter) azelastine nasal spray is used to relieve symptoms of rhinitis such as sneezing and a runny, stuffy, or itchy nose and itchy, watery eyes …
Azelastine Nasal Spray - Cleveland Clinic
AZELASTINE (a ZEL as teen) treats allergy symptoms such as sneezing, itching, or runny or stuffy nose. It works by blocking histamine, a substance released by the body during an …
Azelastine: Side Effects, Uses, Dosage, Interactions, Warnings
Azelastine is used for the treatment of seasonal and perennial allergic rhinitis, and vasomotor rhinitis. Learn about the dosages, side effects, usages, drug interactions, warnings, and more.
Azelastine: Allergy Uses, Side Effects & Dosage - MedicineNet
Feb 1, 2024 · Azelastine is a prescription nasal spray used to treat the symptoms associated with allergic rhinitis (for example, runny nose, nasal itching, and sneezing). Side effects, drug …
